Enrolment Enrolment Pre-randomisation Pre-randomisation Pre-randomisation Pre-randomisation Pre-randomisation Pre-randomisation Follow-up Follow-up Follow-up Follow-up Follow-up Follow-up
PCI (N=105) Placebo (N=95) PCI (N=105) PCI (N=105) PCI (N=105) Placebo (N=95) Placebo (N=95) Placebo (N=95) PCI (N=105) PCI (N=105) PCI (N=105) Placebo (N=95) Placebo (N=95) Placebo (N=95)
Prescribed (%)
Prescribed (%)
Prescribed
Self-reported [days (%)]
HPLC MS/MS detected
Prescribed
Self-reported [days (%)]
HPLC MS/MS detected [% samples tested]
Prescribed
Self-reported [days (%)]
HPLC MS/MS detected
Prescribed
Self-reported [days (%)]
HPLC MS/MS detected [% samples tested]
aspirin 82 (78%) 75 (79%) 102 (97%) 6.95 (99.29 %) - 92 (97%) 6.86 (98.00 %) - 103 (98%) 6.93 (99.00 %) - 91 (96%) 6.81 (97.29 %) -
clopidogrel 40 (38%) 36 (38%) 102 (97%) 7.00 (100.00 %) 66 (96 %) 88 (93%) 7.00 (100.00 %) 52 (90 %) 102 (97%) 6.97 (99.57 %) 91 (98 %) 88 (93%) 6.84 (97.71 %) 68 (94 %)
other AP 2 (2%) 4 (4%) 3 (2%) 7.00 (100.00 %) - 6 (6%) 7.00 (100.00 %) - 3 (3%) 7.00 (100.00 %) - 6 (6%) 6.75 (96.43 %) -
atorvastatin 49 (47%) 47 (49%) 88 (84%) 6.82 (97.43 %) 82 (95 %) 86 (91%) 7.00 (100.00 %) 68 (92 %) 86 (82%) 6.83 (97.57 %) 72 (92 %) 86 (91%) 6.84 (97.71 %) 68 (91 %)
other statin 22 (21%) 19 (20%) 12 (11%) 7.00 (100.00 %) 10 (100 %) 5 (5%) 7.00 (100.00 %) 6 (100 %) 15 (14%) 6.89 (98.43 %) 11 (79 %) 5 (5%) 6.67 (95.29 %) 2 (67 %)
perindopril 4 (4%) 6 (6%) 37 (35%) 7.00 (100.00 %) 37 (95 %) 37 (39%) 6.91 (98.71 %) 33 (97 %) 37 (35%) 6.92 (98.86 %) 29 (85 %) 37 (39%) 6.95 (99.29 %) 30 (100 %)
bisoprolol 32 (30%) 25 (26%) 83 (79%) 7.00 (100.00 %) 79 (98 %) 74 (78%) 7.00 (100.00 %) 66 (99 %) 83 (87%) 6.88 (98.29 %) 73 (96 %) 74 (78%) 6.80 (97.14 %) 62 (97 %)
amlodipine 25 (24%) 31 (33%) 89 (85%) 7.00 (100.00 %) 86 (99 %) 80 (84%) 7.00 (100.00 %) 70 (99 %) 90 (86%) 6.88 (98.29 %) 77 (94 %) 77 (81%) 6.84 (97.71 %) 66 (96 %)
ISMN 26 (25%) 23 (24%) 69 (66%) 6.93 (99.00 %) - 66 (69%) 7.00 (100.00 %) - 69 (66%) 6.96 (99.43 %) - 64 (67%) 6.97 (99.57 %) -
nicorandil 3 (3%) 8 (8%) 49 (47%) 7.00 (100.00 %) 46 (98 %) 59 (62%) 6.94 (99.14 %) 47 (96 %) 49 (47%) 6.97 (99.57 %) 45 (94 %) 57 (60%) 6.97 (99.57 %) 45 (92 %)
ivabradine 0 0 10 (10%) 7.00 (100.00 %) 10 (100 %) 7 (7%) 7.00 (100.00 %) 6 (100 %) 10 (10%) 6.67 (95.29 %) 8 (100 %) 7 (7%) 7.00 (100.00 %) 7 (100 %)
ranolazine 0 0 6 (6%) 7.00 (100.00 %) 7 (100 %) 13 (14%) 7.00 (100.00 %) 13 (100 %) 6 (6%) 7.00 (100.00 %) 6 (100 %) 13 (14%) 6.89 (98.43 %) 13 (100 %)